Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
A Phase 1, Open-Label Study of Sirolimus in Eosinophil-Associated Gastrointestinal Disorders
Status: Enrolling
Updated:  5/31/2017
mi
from
Bethesda, MD
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
A Phase 1, Open-Label Study of Sirolimus in Eosinophil-Associated Gastrointestinal Disorders
Status: Enrolling
Updated: 5/31/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated:  5/31/2017
mi
from
Chicago, IL
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
University of Chicago Medical Center Dept of Onc
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated:  5/31/2017
mi
from
Detroit, MI
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Karmanos Cancer Institute Dept of Onc
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated:  5/31/2017
mi
from
Houston, TX
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
University of Texas/MD Anderson Cancer Center Gastrointestinal Med. Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated:  5/31/2017
mi
from
Bruxelles,
Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
A Phase Ib/II, Open-label Study of LJM716 in Combination With BYL719 Compared to Taxane or Irinotecan in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)
Status: Enrolling
Updated: 5/31/2017
Novartis Investigative Site
mi
from
Bruxelles,
Click here to add this to my saved trials
Safety & Prevention Outcomes Study
A Brief Prescription Opioid Overdose Intervention in an Emergency Department
Status: Enrolling
Updated:  5/31/2017
mi
from
Ann Arbor, MI
Safety & Prevention Outcomes Study
A Brief Prescription Opioid Overdose Intervention in an Emergency Department
Status: Enrolling
Updated: 5/31/2017
University of Michigan Health System Emergency Department
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Parasitic Infections of the Gastrointestinal Tract
Study of Patients With Parasitic Infections of the Gastrointestinal Tract
Status: Enrolling
Updated:  6/1/2017
mi
from
Bethesda, MD
Parasitic Infections of the Gastrointestinal Tract
Study of Patients With Parasitic Infections of the Gastrointestinal Tract
Status: Enrolling
Updated: 6/1/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated:  6/7/2017
mi
from
Miami, FL
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated:  6/7/2017
mi
from
Orlando, FL
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated:  6/7/2017
mi
from
Minneapolis, MN
A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
An Open-Label Parallel-Group Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects
Status: Enrolling
Updated: 6/7/2017
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Status: Enrolling
Updated:  6/8/2017
mi
from
Pittsburgh, PA
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Gram Negative Bacteremia, Risk Factors for Failure of Therapy
Status: Enrolling
Updated: 6/8/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  6/8/2017
mi
from
Orlando, FL
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 6/8/2017
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated:  6/8/2017
mi
from
Orlando, FL
A Study To Describe The Effect Of Impaired Hepatic Function Of The Pharmacokinetics Of Palbociclib
A Phase 1, Open-label, Single Dose, Parallel-cohort Study To Evaluate The Pharmacokinetics Of Palbociclib (Pd-0332991) In Subjects With Impaired Hepatic Function
Status: Enrolling
Updated: 6/8/2017
Weston Diagnostics (Ultrasound Facility)
mi
from
Orlando, FL
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated:  6/14/2017
mi
from
Durham, NC
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated:  6/14/2017
mi
from
Cleveland, OH
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated:  6/14/2017
mi
from
Hershey, PA
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated:  6/14/2017
mi
from
Knoxville, TN
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
The University of Tennessee
mi
from
Knoxville, TN
Click here to add this to my saved trials
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated:  6/14/2017
mi
from
Richmond, VA
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Zenapro™ Hybrid Hernia Repair Device for Ventral Hernia Repair
Status: Enrolling
Updated: 6/14/2017
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated:  6/15/2017
mi
from
Los Angeles, CA
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated:  6/15/2017
mi
from
Denver, CO
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
University of Colorado at Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated:  6/15/2017
mi
from
Tampa, FL
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated:  6/15/2017
mi
from
Houston, TX
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps: "You Can Look But You Can't Touch"
Status: Enrolling
Updated: 6/15/2017
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Simultaneous Integrated Boost (SIB) in Esophageal Cancer
Phase I/II Study of Evaluating the Safety and Efficacy of Using a Simultaneous Integrated Boost for Dose Escalation in Patients With Esophageal Cancer
Status: Enrolling
Updated:  6/19/2017
mi
from
Houston, TX
Simultaneous Integrated Boost (SIB) in Esophageal Cancer
Phase I/II Study of Evaluating the Safety and Efficacy of Using a Simultaneous Integrated Boost for Dose Escalation in Patients With Esophageal Cancer
Status: Enrolling
Updated: 6/19/2017
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
GSK962040 Drug-drug Interaction Study With Ketoconazole
An Open-label, Randomized, Single Sequence, Two Period Study to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of GSK962040 in Healthy Volunteers
Status: Enrolling
Updated:  6/19/2017
mi
from
Buffalo, NY
GSK962040 Drug-drug Interaction Study With Ketoconazole
An Open-label, Randomized, Single Sequence, Two Period Study to Assess the Effect of Repeat Oral Dosing of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of GSK962040 in Healthy Volunteers
Status: Enrolling
Updated: 6/19/2017
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Hepatoma and Other Advanced Solid Tumors
Status: Enrolling
Updated:  6/22/2017
mi
from
New York, NY
Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
A Phase 1 Dose-Escalation Study of the Safety and Clinical Effects of ON 01910.Na in Combination With Either Irinotecan or Oxaliplatin in Patients With Hepatoma and Other Advanced Solid Tumors
Status: Enrolling
Updated: 6/22/2017
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated:  6/26/2017
mi
from
Tucson, AZ
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated:  6/26/2017
mi
from
Castro Valley, CA
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
Center for Clinical Research
mi
from
Castro Valley, CA
Click here to add this to my saved trials
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated:  6/26/2017
mi
from
Newnan, GA
NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers
A Multi-center, Randomized, Parallel, Crossover Design Study of Non-healing Diabetic Foot Ulcers, Treated With Cryopreserved, Umbilical Cord Allograft (NEOX® CORD 1K) Versus Standard of Care That Are Followed for 12 Weeks
Status: Enrolling
Updated: 6/26/2017
Ankle and Foot Centers of Georgia
mi
from
Newnan, GA
Click here to add this to my saved trials
Study Comparing Rifaximin With Xifaxan 200mg in Traveler's Diarrhea
A Randomized, Double-Blind, Parallel, Multicenter, Bioequivalence Study Comparing Rifaximin 200-mg Tablets With Xifaxan® 200-mg Tablets and With Placebo in the Treatment of Traveler's Diarrhea
Status: Enrolling
Updated:  6/26/2017
mi
from
Coral Gables, FL
Study Comparing Rifaximin With Xifaxan 200mg in Traveler's Diarrhea
A Randomized, Double-Blind, Parallel, Multicenter, Bioequivalence Study Comparing Rifaximin 200-mg Tablets With Xifaxan® 200-mg Tablets and With Placebo in the Treatment of Traveler's Diarrhea
Status: Enrolling
Updated: 6/26/2017
Clinical Research Facility
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Prevention of Parastomal Hernia by Mesh Placement
A Randomized Study of the Utility of Composite Mesh Placement to Prevent Parastomal Hernia in Patients Undergoing Urinary Diversion With Ileal Conduit
Status: Enrolling
Updated:  6/27/2017
mi
from
Miami, FL
Prevention of Parastomal Hernia by Mesh Placement
A Randomized Study of the Utility of Composite Mesh Placement to Prevent Parastomal Hernia in Patients Undergoing Urinary Diversion With Ileal Conduit
Status: Enrolling
Updated: 6/27/2017
University of Miami Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Neurocognitive Effects of Opiate Agonist Treatment
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated:  7/5/2017
mi
from
The Bronx, NY
Neurocognitive Effects of Opiate Agonist Treatment
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated: 7/5/2017
Fordham University
mi
from
The Bronx, NY
Click here to add this to my saved trials
Neurocognitive Effects of Opiate Agonist Treatment
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated:  7/5/2017
mi
from
The Bronx, NY
Neurocognitive Effects of Opiate Agonist Treatment
Neurocognitive Effects of Opiate Agonist Treatment
Status: Enrolling
Updated: 7/5/2017
The Albert Einstein College of Medicine of Yeshiva University
mi
from
The Bronx, NY
Click here to add this to my saved trials
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Status: Enrolling
Updated:  7/10/2017
mi
from
Durham, NC
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Insulin Resistance in Nonalcoholic Fatty Liver Disease: A Case Control Study
Status: Enrolling
Updated: 7/10/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Randomized Treatment of Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Status: Enrolling
Updated:  7/17/2017
mi
from
Sioux Falls, SD
Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Randomized Treatment of Neuromuscular Electrical Stimulation (NMES) for Dysphagia in Neonates
Status: Enrolling
Updated: 7/17/2017
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Clotrimazole Enemas for Pouchitis in Children and Adults
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated:  7/18/2017
mi
from
Boston, MA
Clotrimazole Enemas for Pouchitis in Children and Adults
Clotrimazole Enemas for Pouchitis in Children and Adults
Status: Enrolling
Updated: 7/18/2017
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
mi
from
Cincinnati, OH
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated:  7/18/2017
mi
from
Charlottesville, VA
Self-Management Assistance for Recommended Treatment (SMART) Portal
Self-Management Assistance for Recommended Treatment (SMART) Portal
Status: Enrolling
Updated: 7/18/2017
BeHealth Solutions, LLC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Individualized Infiximab Dosing-Proof of Concept Study
Individualized Infiximab Dosing-Proof of Concept Study
Status: Enrolling
Updated:  7/18/2017
mi
from
Los Angeles, CA
Individualized Infiximab Dosing-Proof of Concept Study
Individualized Infiximab Dosing-Proof of Concept Study
Status: Enrolling
Updated: 7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated:  7/18/2017
mi
from
Los Angeles, CA
The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients
The Role of Small Bowel Ultrasound After Ileocolic Resection or When Starting Infliximab in Crohn's Disease Patients
Status: Enrolling
Updated: 7/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vitamin D Levels Following Topical Application of Vitamin D Ointment
Vitamin D Levels in Subjects With Vitamin D Deficiency Following Topical Application of Three Doses of Vitamin D Ointment - A Proof of Concept Study
Status: Enrolling
Updated:  7/19/2017
mi
from
Saint Paul, MN
Vitamin D Levels Following Topical Application of Vitamin D Ointment
Vitamin D Levels in Subjects With Vitamin D Deficiency Following Topical Application of Three Doses of Vitamin D Ointment - A Proof of Concept Study
Status: Enrolling
Updated: 7/19/2017
University of Minnesota Physicians - Phalen Village Clinic
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
Double-blind, Dose-response, Randomised, Placebo-controlled, Parallel Group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
Status: Enrolling
Updated:  7/20/2017
mi
from
New Smyrna Beach, FL
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
Double-blind, Dose-response, Randomised, Placebo-controlled, Parallel Group, Multi-centre Phase III Clinical Study on the Efficacy and Tolerability of Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
Status: Enrolling
Updated: 7/20/2017
United Medical Research
mi
from
New Smyrna Beach, FL
Click here to add this to my saved trials
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status: Enrolling
Updated:  7/24/2017
mi
from
Buffalo, NY
A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
A Single Centre, Single Sequence, Open-Label, Repeat-Dose Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects
Status: Enrolling
Updated: 7/24/2017
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated:  7/27/2017
mi
from
Hialeah, FL
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated: 7/27/2017
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated:  7/27/2017
mi
from
Orlando, FL
An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)
A Two-Part, Open-Label Study to Investigate the Single-Dose Pharmacokinetics of MK-8931 When Administered to Subjects With Mild and Moderate Hepatic Insufficiency
Status: Enrolling
Updated: 7/27/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Utility of Aberrant Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Status: Enrolling
Updated:  8/1/2017
mi
from
Rochester, MN
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Utility of Aberrant Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Status: Enrolling
Updated: 8/1/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Status: Enrolling
Updated:  8/3/2017
mi
from
New York, NY
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy.
The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Status: Enrolling
Updated: 8/3/2017
NYU Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Incisional Hernia and Adhesion-Related Bowel Obstruction
Incisional Hernia and Adhesion-Related Bowel Obstruction After Open and Laparoscopic Colorectal Surgery: A Prospective Cohort Study
Status: Enrolling
Updated:  8/3/2017
mi
from
Cleveland, OH
Incisional Hernia and Adhesion-Related Bowel Obstruction
Incisional Hernia and Adhesion-Related Bowel Obstruction After Open and Laparoscopic Colorectal Surgery: A Prospective Cohort Study
Status: Enrolling
Updated: 8/3/2017
Cleveland Clinic Colorectal Surgery Department
mi
from
Cleveland, OH
Click here to add this to my saved trials
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
A Randomized Study to Evaluate the Effect of Switching From Efavirenz to Atazanavir/ Ritonavir on Lipoatrophy and Mitochondrial Dysfunction in HIV-infected Subjects With Good Virologic Suppression
Status: Enrolling
Updated:  8/10/2017
mi
from
Cleveland, OH
Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression
A Randomized Study to Evaluate the Effect of Switching From Efavirenz to Atazanavir/ Ritonavir on Lipoatrophy and Mitochondrial Dysfunction in HIV-infected Subjects With Good Virologic Suppression
Status: Enrolling
Updated: 8/10/2017
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Domperidone in Refractory Gastroparesis
Domperidone in Refractory Gastroparesis
Status: Enrolling
Updated:  8/17/2017
mi
from
New Haven, CT
Domperidone in Refractory Gastroparesis
Domperidone in Refractory Gastroparesis
Status: Enrolling
Updated: 8/17/2017
Yale Digestive Diseases 40 Temple St, Suite 1A
mi
from
New Haven, CT
Click here to add this to my saved trials
Nicotine Gum Recovery After Colorectal Surgery
Does Nicotine Gum Enhance Bowel Recovery After Colorectal Surgery?
Status: Enrolling
Updated:  8/21/2017
mi
from
Weston, FL
Nicotine Gum Recovery After Colorectal Surgery
Does Nicotine Gum Enhance Bowel Recovery After Colorectal Surgery?
Status: Enrolling
Updated: 8/21/2017
Cleveland Clinic Florida
mi
from
Weston, FL
Click here to add this to my saved trials